University of Texas Health Science Center at Tyler Internal Medicine

Topics

• Tuberculosis Research and Epidemiology 49
• Lung Cancer Treatments and Mutations 34
• Cardiovascular Function and Risk Factors 31
• Heart Failure Treatment and Management 26
• Cancer Immunotherapy and Biomarkers 23
• Head and Neck Cancer Studies 17
• Cardiovascular and exercise physiology 16
• Physical Activity and Health 16
• Blood Pressure and Hypertension Studies 13
• Cardiac Imaging and Diagnostics 11
• Diabetes, Cardiovascular Risks, and Lipoproteins 11
• Lung Cancer Diagnosis and Treatment 11

Most cited

1. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Erminia Massarelli

2. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · Erminia Massarelli

3. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 813 citations · Erminia Massarelli

4. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 469 citations · Erminia Massarelli

5. Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes.

   Current drug targets · 2021 · 574 citations · Zahi Merjaneh

6. Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.

   The New England journal of medicine · 2023 · 280 citations · Erminia Massarelli